跳至主要内容
临床试验/CTRI/2022/08/044856
CTRI/2022/08/044856
尚未招募
2 期

A randomized control trial to determine the efficacy and schedule of oral calcium supplementation for prevention of adverse citrate reaction in plateletpheresis donors.

AIIMS Delhi0 个研究点目标入组 0 人待定

概览

阶段
2 期
干预措施
未指定
疾病 / 适应症
未指定
发起方
AIIMS Delhi
状态
尚未招募
最后更新
3年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
3年前
研究类型
Interventional

研究者

发起方
AIIMS Delhi

入排标准

入选标准

  • Donors eligible for plateletphersis as per the Drugs and Cosmetics Act 1940; Rule 1945 (Amendment 2020\) (DCA)

排除标准

  • i.Donors eligible as per the DCA but found to be reactive in transfusion transmitted infectious disease screening testing
  • ii.Donors already on calcium, or Vitamin D supplements.
  • iii.Donors with incomplete procedure due to reason other than hypocalcemic adverse reactions.
  • iv.Donors with incomplete procedure due to technical reasons.

结局指标

主要结局

未指定

相似试验